NCT02483637View on ClinicalTrials.gov

Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

May 31, 2019

Study Completion Date

May 20, 2022

Conditions
Bronchitis, ChronicCryotherapy Effect
Interventions
DEVICE

RejuvenAir

Device: RejuvenAir

Trial Locations (3)

Unknown

St. Paul's Hospital, Vancouver

University Medical Center Groningen, Groningen

SW10 9NH

Chelsea and Westminster Hosptial/Royal Brompton Hosptial, London

Sponsors

Lead Sponsor

CSA Medical, Inc.
All Listed Sponsors
lead

CSA Medical, Inc.

INDUSTRY